glp-1 agonists vision loss blindness Recent studies have begun to explore a possible link between receptor (like semaglutide) and a rare but serious cause of sudden known as non-arteritic anterior ischemic Researchers Find Small Increased Risk
Description
All that insulin triggers your ovaries to pump out extra androgens, leading to PCOS symptoms

Next, we took advantage of the known actions of islet incretin receptors on glucagon secretion from alpha cells as an orthogonal approach to assess the relative contribution of tirzepatide at each receptor

The researchers of that study called for urgent clarification of drug- and patient-related risk factors, an understanding that has become more important as GLP-1 receptor agonist use continues to rise across the United States, especially for weight management

[DOI] [PMC free article] [PubMed] [Google Scholar] 11.Whytock KL, Carnero EA, Vega RB, Tillner J, Bock C, Chivukula K, et al
Diabetes Care 46 , 249251 (2023)
